Page 1,536«..1020..1,5351,5361,5371,538..1,5501,560..»

Untreated sleep apnea may worsen markers of heart health and … – Washington Post

Posted: June 18, 2017 at 8:40 pm

By Reuters By Reuters June 17

Properly treating a common sleep-related breathing disorder may have benefits for the heart and for blood sugar, a new study suggests.

If people with obstructive sleep apnea dont use machines at night to help keep the airway open, measures of their heart health and blood sugar worsen, researchers found.

One of the long-standing debates in our field is whether sleep apnea causes heart issues and problems with blood sugar or if theyre just associated, said the studys senior author, Jonathan Jun of Johns Hopkins University.

In obstructive sleep apnea, the airway intermittently collapses or becomes blocked during sleep. The blocked airway causes pauses in breathing. Some people address this by using CPAP continuous positive airway pressure machines at night to keep the airway open.

In the past, researchers have tried to directly link sleep apnea with heart health and blood sugar by comparing patients instructed to use CPAP devices with patients instructed to sleep without these machines. But one of the major issues with those studies is that people may not actually use the CPAP machine, Jun said by phone.

For the new study, the researchers recruited 31 people with moderate to severe obstructive sleep apnea who were known to regularly use CPAP machines.

The participants slept two nights in a lab, using their CPAP device on only one of the nights. The researchers obtained blood samples while participants slept.

We are looking at real-time changes, Jun said. Were getting blood every 20 minutes.

As reported in the Journal of Clinical Endocrinology and Metabolism, on the night without CPAP, patients obstructive sleep apnea returned. On those nights, the participants had low levels of oxygen in their blood, poor sleep and an increased heart rate.

Additionally, their blood samples showed increases in fatty acids, sugar and the stress hormone cortisol.

The researchers also saw increases in blood pressure and arterial stiffness, which has been linked with a risk for heart problems.

These were obese patients and patients with relatively severe sleep apnea. They also had other medical problems, Jun pointed out. People who fit that description may be experiencing the same changes if they sleep without using a CPAP machine, he said.

Glucose and fatty acids rose in the overall group without the CPAP machines, but participants with diabetes may be more vulnerable to the glucose elevation, Jun warned.

He said the study cant say what would happen to people with milder sleep apnea.

Because obesity has been tied to an increased risk of sleep apnea, it has been difficult to know whether its sleep apnea or obesity that is causing those problems, Jun noted.

The new study, he said, advances that idea that other conditions and not obesity itself are drivers of those levels.

Read more

Exercise can improve the symptoms of sleep apnea

Snoring may be benign, or it may be a sign of a serious problem

See the original post here:
Untreated sleep apnea may worsen markers of heart health and ... - Washington Post

Posted in Diabetes | Comments Off on Untreated sleep apnea may worsen markers of heart health and … – Washington Post

ASA Provides Input to USDA, FDA on Advances in Biotechnology – KTIC

Posted: June 17, 2017 at 9:42 am

The American Soybean Association (ASA) submitted comments this week to both the U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) regarding regulations in response to advances in genetic engineering.

ASA included in comments to USDA, that biotechnology is an essential tool in farmers quest to produce enough food to meet the needs of 9.7 billion people by 2050, creating the need for a clear, science-based regulatory system in the U.S. as an example and standard for regulatory systems of biotechnology internationally.

While applauding USDAs efforts to reduce the burden on regulated entities, ASA expressed concern that aspects of the rule as proposed will increase the regulatory burden and stifle research and innovation.

Additionally, ASAs comments to FDA cheered USDAs proposal to exclude certain genome-editing techniques from requiring pre-market approvals because they are low risk and could be found in nature or achieved through traditional breeding methods.

ASA concluded its support saying, Technological advancements such as genome editing offer an additional tool to combat threats while also improving sustainability in production agriculture.

Full comments to USDA and FDA can be found here and here, respectively.

See the original post here:
ASA Provides Input to USDA, FDA on Advances in Biotechnology - KTIC

Posted in Biotechnology | Comments Off on ASA Provides Input to USDA, FDA on Advances in Biotechnology – KTIC

$10M for birthplace of biotechnology – Innovators Magazine

Posted: June 17, 2017 at 9:42 am

(CALIFORNIA)

Thebirthplace of biotechnology is to receive$10 million for a pioneering precision medicine programme.

It was announced this week thatthe California Initiative to Advance Precision Medicine (CIAPM) has been awarded the money from the local governments budget, a decision welcomed by theCalifornia Life Sciences Association (CLSA).

Sara Radcliffe, President & CEO, CLSA, said:California Life Sciences Association (CLSA) applauds Governor Jerry Brown, California State Senate and California Assembly leaders for their strong support of life sciences innovation, as demonstrated again in this years 2017-2018 budget deal which allocates a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the states life sciences sector employs over 287,200 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients.

The Californian city of San Diego ishostingtheBIO International Conventionalthe global event for biotechnology next week. It will celebrate the industrys many breakthroughs and on going impact on society.It will take place at the San Diego Convention Center between 19 and 22 June.

BIO International ConventionalCalifornia Initiative to Advance Precision Medicine

Read the rest here:
$10M for birthplace of biotechnology - Innovators Magazine

Posted in Biotechnology | Comments Off on $10M for birthplace of biotechnology – Innovators Magazine

Texas has sanctioned unapproved stem cell therapies. Will it change anything? – Science Magazine

Posted: June 17, 2017 at 9:42 am

Texas Governor Greg Abbott just signed a law making it easier for unproven stem cell therapies to be given to patients in his state.

Marjorie Kamys Cotera/Bob Daemmrich Photography/Alamy Stock Photo

By Kelly ServickJun. 15, 2017 , 11:15 AM

Texas Governor Greg Abbott yesterday signed a bill allowing clinics and companies in the state to offer people unproven stem cell interventions without the testing and approval required under federal law. Like the right to try laws that have sprung up in more than 30 states, the measure is meant to give desperately ill patients access to experimental treatments without oversight from the U.S. Food and Drug Administration (FDA).

In a state where unproven stem cell therapies are already offered widely with little legal backlash, bioethicists and patient advocates wonder whether the states official blessing will maintain the status quo, tighten certain protections for patients, or simply embolden clinics already profiting from potentially risky therapies.

You could make the argument thatif [the new law] was vigorously enforcedits going to put some constraints in place, says Leigh Turner, a bioethicist at the University of Minnesota in Minneapolis, who last year co-authored a study documenting U.S. stem cell clinics marketing directly to consumers online, 71 of which were based in Texas. But it would really be surprising if anybody in Texas is going to wander around the state making sure that businesses are complying with these standards, he adds. Either way, Turner says theres powerful symbolic value in setting up this conflict between state law and federal law.

The law, effective 1 September, will allow people with severe chronic or terminal illness to be treated at a clinic that purports to isolate therapeutic stem cells from adult tissuesuch as a patients own fatif their doctor recommends it after considering all other options, and if its administered by a physician at a hospital or medical school with oversight from an institutional review board (IRB). It also requires that the same intervention already be tested on humans in a clinical trial. The law sanctions a much broader set of therapies than federal rules, which already exempt certain stem cell interventions from FDAs lengthy approval process, provided the cells are only minimally manipulated and perform the same function they normally have in body.

The Texas bills clinical trial and IRB requirements seem to weed out some dubious therapies, but the language is too nebulous to protect patients, says Beth Roxland, a bioethicist at New York Universitys Langone Medical Center in New York City. The bill doesnt specify that a trial be conducted in the United States or that the therapy get clearance from FDA for human testing. You could gain access to something [as long as its] being studied in a human somewhere on the planet, she says, which in the stem cell area makes it really very scary.

Awareness about the risks of unproven stem cell therapies is growing. A case report published in The New England Journal of Medicine earlier this year documented three women who lost their vision after receiving purported stem cell injections meant to treat age-related degeneration of the retina. Such risks are also the subject of a news conference today at the annual meeting of the International Society for Stem Cell Research in Boston.

Roxland is also unnerved by a provision in the Texas law that would prevent any state government entity from interfering with a patients access to treatment. Hypothetically, if a state officially gets wind of nefarious doings at a for-profit clinic the state officials are now restrained from doing anything. She notes that that language mirrors a proposal in a federal bill known as the Trickett Wendler Right to Try Act, introduced in the Senate in January, which would prevent the federal government from interfering with a terminally ill patients access to an experimental drug outside of a clinical trial, and would prevent FDA from considering those patients outcomes in its drug approval decisions. Vice President Mike Pence signaled his support for the law in February and met with the family of Trickett Wendler, who advocated for right to try laws before her death from amyotrophic lateral sclerosis in 2015.

Others also believe that the Texas laws approval might signal a coming thaw in federal regulation of stem cell clinics. The FDA obviously doesnt have the manpower to watch over these people, says David Bales, chairman of the advocacy group Texans for Cures in Austin, which pushed for more patient protections in the new bill. We really feel like theyre trying to open up the floodgates.

See the rest here:
Texas has sanctioned unapproved stem cell therapies. Will it change anything? - Science Magazine

Posted in Cell Medicine | Comments Off on Texas has sanctioned unapproved stem cell therapies. Will it change anything? – Science Magazine

Pierre Coulombe, Ph.D. to lead UM Department of Cell & Developmental Biology – University of Michigan Health System News (press release)

Posted: June 17, 2017 at 9:42 am

ANN ARBOR, MI One of the oldest departments at the University of Michigan is about to get a new leader. The U-M Board of Regents today approved the appointment of Pierre A. Coulombe, Ph.D., to lead the Department of Cell and Developmental Biology in the Medical School.

Coulombe will become chair on August 1, and lead one of the nine basic science departments of Michigan Medicine, U-Ms academic medical center. The departments researchers study how structure governs function in cells and tissues throughout the body, and how complex arrays of signals are integrated to foster the proper development of tissues and organs. They also study stem cells, including embryonic stem cells, and train undergraduate, graduate and medical students in cell biology.

The department traces its roots back to 1854, soon after the founding of the Medical School, when it was known as the Department of Anatomy.

Coulombe comes to Michigan from Johns Hopkins University, where he chaired the Department of Biochemistry and Molecular Biology in the Bloomberg School of Public Health for nine years, and held the E.V. McCollum professorship as well as several joint appointments in the School of Medicine. At Hopkins, Coulombe was noted for recruiting and nurturing junior faculty members to success, and developing robust training programs for graduate students and post-doctoral fellows. He was also instrumental in addressing the departments infrastructure needs.

To me, cell and developmental biology are critically important endeavors as one seeks to translate the wealth of knowledge acquired in biochemistry and molecular biology, along with the power of imaging techniques, into a better understanding of how organs and tissues form, and operate, under normal and disease conditions, he says. This knowledge is also important for developing novel therapies for human disease. U-M already is a formidable institution, and otherwise is making a substantial investment into biomedical research. Therefore, I am absolutely thrilled about the opportunity to lead Cell & Developmental Biology, and team up with my new colleagues in the department and at U-M, to fulfill this potential.

In addition to his appointment in Cell & Developmental Biology, Coulombe will have a joint appointment in the U-M Department of Dermatology. His research focuses on understanding how keratin proteins and the nanoscale filaments they form foster an optimal architecture and function in skin and related epithelia, and how disruption of these processes result in diseases ranging from inherited conditions to cancer.

A native of Montral, Qubec, Coulombe earned his undergraduate degree from the Universit du Qubec Montral and his Ph.D. in Pharmacology from Universit de Montral. He completed his postdoctoral fellowship in the Department of Molecular Genetics and Cell Biology & Howard Hughes Medical Institute at the University of Chicago before joining Johns Hopkins School of Medicine in 1992. He is the author of more than 140 peer-reviewed publications and one book, holds one patent, and has received multiple awards in recognition of his research and teaching endeavors.

For more about the U-M Department of Cell and Developmental Biology, visit https://medicine.umich.edu/dept/cell-developmental-biology.

Continued here:
Pierre Coulombe, Ph.D. to lead UM Department of Cell & Developmental Biology - University of Michigan Health System News (press release)

Posted in Cell Medicine | Comments Off on Pierre Coulombe, Ph.D. to lead UM Department of Cell & Developmental Biology – University of Michigan Health System News (press release)

On the cusp of payoffs for patients, stem cell therapy faces threat from unregulated clinics – STAT

Posted: June 17, 2017 at 9:41 am

TV documentary on pain treatment funded by doctor with

TV documentary on pain treatment funded by doctor with industry ties

For some chronic pain patients, without opioids, life would

For some chronic pain patients, without opioids, life would be torture

Googles bold bid to transform medicine hits turbulence under

Googles bold bid to transform medicine hits turbulence under a divisive CEO

At first meeting of Trumps opioid commission, health advocates

At first meeting of Trumps opioid commission, health advocates plead for Medicaid spending

This bill would reinstate a controversial drug discount for

This bill would reinstate a controversial drug discount for some hospitals

Up and down the ladder: The latest comings and

Up and down the ladder: The latest comings and goings

See original here:
On the cusp of payoffs for patients, stem cell therapy faces threat from unregulated clinics - STAT

Posted in Cell Therapy | Comments Off on On the cusp of payoffs for patients, stem cell therapy faces threat from unregulated clinics – STAT

Broccoli Could Be a Secret Weapon Against Diabetes, Say Scientists – ScienceAlert

Posted: June 17, 2017 at 9:41 am

Broccoli contains an ingredient that can help those with type 2 diabetes control their blood sugar level, according to a new study potentially providing a much-needed treatment option for millions.

A chemical in cruciferous vegetables like broccoli and sprouts calledsulforaphaneis thought to be responsible,having been shown to lower glucose levels in earlier lab experiments on diabetic rats.

To identify suitable compounds to examine, researchers used computer models to identify gene expression changes linked with type 2 diabetes, and then sift through thousands of chemicals that might reverse these changes.

"We're very excited about the effects we've seen and are eager to bring the extract to patients," one of the researchers, Anders Rosengren of the University of Gothenburg in Sweden, told Andy Coghlan at New Scientist.

"We saw a reduction of glucose of about 10 per cent, which is sufficient to reduce complications in the eyes, kidneys and blood."

That 10 percent average reduction was across a sample of 97 human volunteers taking part in a 12-week randomised, placebo-controlled trial. The participants who were obese and who had higher baseline glucose levels to begin with benefitted the most.

The dose was the equivalent of around 5 kilograms (11 pounds) of broccoli daily a fair few platefuls but the researchers say it could be adapted into a powder to add to food or drinks.

It's important to note that all but three of those taking part in the trial continued to take metformin, a drug already used to improve blood sugar regulation in people with diabetes.

However, the researchers think sulforaphane could eventually replace metformin for some patients up to 15 percent of those with diabetes can't take metformin because of the associated risks of kidney damage.

The two chemicals take different approaches: sulforaphane suppresses the enzymes in the liver that stimulate glucose production, whereas metformin makes cells more sensitive to insulin, taking more glucose out of the bloodstream.

With more than 29 million people having type 2 diabetes in the US alone, and that number on the rise, any kind of help is going to be very welcome.

Before the human trial, the researchers also found sulforaphane was able to reduce glucose production in liver cells grown in a lab, and shift liver gene expression away from an abnormal, diseased state in diabetic rats.

Larger and more detailed studies are required before the drug can get approved for regular treatments though, and until then it's probably wise to keep your vegetable intake to a normal, healthy level.

"More research is needed to see if this repurposed drug can be used to treat Type 2 diabetes, as it was only tested in a small number of people and only helped a subset of those who are taking it," Elizabeth Robertson from Diabetes UK, who wasn't involved in the research, told New Scientist.

"For now, we recommend that people continue with the treatment prescribed by their healthcare team."

The findings have been published in Science Translational Medicine.

Continued here:
Broccoli Could Be a Secret Weapon Against Diabetes, Say Scientists - ScienceAlert

Posted in Diabetes | Comments Off on Broccoli Could Be a Secret Weapon Against Diabetes, Say Scientists – ScienceAlert

Diabetes camp educates, entertains – Hastings Tribune

Posted: June 17, 2017 at 9:41 am

Sometimes its good to just be one of the gang.

This is certainly true for those dealing with Type 1 diabetes. And thats why Camp Hot Shots has become a favorite get-away destination for hundreds of youngsters ages 6-12 in central Nebraska since 2001.

Founded by Mary Lanning Heathcare and presented this year in partnership with Grace United Methodist Church, the two-day camp gives youngsters dealing with the disease a chance to bond with fellow diabetics without having to address those intrusive questions so often posed by their well-meaning but unmindful peers.

DeAnn Carpenter, program coordinator for Mary Lannings diabetes program, said the camp which is funded in part through donations from area organizations combines diabetes education and a host of fun activities to create an experience many campers have come to look forward to year after year.

More than 20 area children are taking part in this years long list of camp activities, which include: Boat rides and water play at Lake Hastings and Aquacourt Water Park, YMCA play, string art, balloon artist/magician Poppin Penelope, taekwondo, and more.

Its just a time for kids who have Type 1 diabetes to come together and realize theyre not alone, Carpenter said. A lot of them are the only ones in their school system or community who have Type 1 diabetes and maybe feel a little alone, having to take care of themselves. Its a time to bond and interact with people who have the same diagnosis as them.

For many campers, the camp has become an annual tradition, a place to bond with new found friends over shared activities. In some instances, it may be the only contact they have with their fellow diabetic companions each year.

For Braden Benjamin, 12, of Friend, this year marks his seventh go-around in the camp.

I like coming to the lake and swimming and tubing with my friends, he said. I get to see other diabetics that Im not around very often. I know most of them, but there are a few new ones every now and then.

I also like going to the YMCA. They have a bunch of different activities, like tennis and racquetball. You can go to the batting cage, and theres a pool there, too.

But its the camaraderie with fellow diabetics that makes the camp experience special to himself and fellow participants, he said.

The camp allows me to talk to other diabetics that I dont get to see very often. Its just nice to be around other people who share the disease that you have and know what it feels like. I hope to make more friends at the camp this year and get better at taking care of my diabetes. If my blood sugars are good I can pretty much do anything if I treat it beforehand.

Kordell Lovitt, 13, of Chapel, is attending the camp for the fourth straight year. Like most all of his fellow campers, he considers the lake activities the high water point of the two-day outing.

Im just swimming and having fun with my friends that I dont see a lot, he said. We talk about how we take care of our diabetes and how we treat our lows and highs. It (diabetes) is kind of stressful, but sometimes I just get over it.

And camp is a big reason for that, he said.

The others tell me what I dont do right and that I can do a better job of it, he said. I check on my blood sugars often here to keep them in range.

Having to explain himself and his limitations to non-diabetics day in and day out makes coming to camp seem even more of a getaway experience each year.

When people ask me, Why do you have to do this? its kind of weird and awkward, he said. Here, I dont have to tell them anything. I just want to have fun and pay attention to my diabetes.

Fourth-time camper Emmilly Berglund, 12, of Shelton said she felt right at home navigating the lakeside waters with friends of a feather.

I just like to come and see the other kids and talk to them about how everything is, she said. Its just enjoyable and relaxing to hang around other kids who have it (Type 1 diabetes). Im looking forward to the new activities they have this year like string art and going to the water park and learning new things.

Lee Wigert, 65, is a teacher at Hastings College and pastor of United Methodist churches in Juniata, Holstein and Kenesaw.

He, along with his wife, Diane, and son, Nate, 32, who has diabetes, have been donating their time giving boat and jet ski rides and sharing their back yard abutting Lake Hastings for the past decade.

Its just amazing the bonding experience that these children have, he said. The kids come back year after year and call you by name and you remember them. I spend about three days getting the house ready and tubes and trampoline blown up.

We make sure everybody gets on the boat. What they take away from this is that they know the adults care for them and are here to help them out.

See the rest here:
Diabetes camp educates, entertains - Hastings Tribune

Posted in Diabetes | Comments Off on Diabetes camp educates, entertains – Hastings Tribune

Expand coverage for diabetes treatment | Sally Hillerich Galla – The Courier-Journal

Posted: June 17, 2017 at 9:40 am

Sally Hillerich Galla, Guest Contributor 3:13 p.m. ET June 15, 2017

Measuring blood sugar(Photo: Maya23K, Getty Images/iStockphoto)

It might be old-fashioned, but as a young child growing up in Kentucky, I was taught never to reveal my age. Yet to understand my story, you have to start with a number: Im 65, and Im incredibly fortunate to be alive.

At the age of 24, my doctor gave me six months to live, along with one last hope: an emergency surgery to treat the endometriosis which was threatening my life. Thankfully, that surgery was a success.

But my medical journey was just beginning.

In the weeks after my surgery, I lost 30 pounds, and my vision was getting increasingly blurry. A trip back to my doctor confirmed a new, equally troubling and unrelated diagnosis: Type-1 diabetes. At the time, the outlook for Type-1 patients was grim.

Like every person with Type-1 Diabetes, not a day goes by that I dont spend thinking about and treating my disease. But there are some risk factors beyond our control, notably that Medicare, unlike nearly every private insurance plan, wont pay for some treatments that helpus stay healthy.

To start, it helps to understand that Type-1 Diabetes keeps your pancreas from producing insulin, so those of us living with the disease must inject the right amount of insulin ourselves, using everything from needles to traditional insulin pumps. Youve probably seen these pumps; a patch is connected by tubes to a device clipped to your belt or placed in your pocket.

More: New health bill even worse threat for Kentuckians | Comment

More: Poverty, obesity fuel Ky's diabetes epidemic

More: Help list: Learn to avoid or manage diabetes

Devices like this come with significant drawbacks. They cant get wet, and patients with neuropathy and arthritis have a hard time connecting and re-connecting the tubes multiple times a day. However, they do have one major benefit: theyre covered by Medicare.

The device I use called an Omnipod isnt.

My Omnipod is a wireless pump; a small pod that can be worn nearly anywhere and is connected wirelessly to a device about the size of a cell phone, which doesnt have to be clipped to your clothing. Instead, it just has to be close by.

And this is where that bureaucratic thinking comes in. All other insulin pumps are paid for under Medicare Part B because theyre considered durable medical equipment.

But the Omnipod isnt.

Thats because the Omnipod is different. Each of the pods lasts three days. Once its supply of insulin is used up, you replace it with another. You keep the cell phone-sized transmitter, which connects wirelessly to each new pod. Yet even though it has been approved by the FDA for 12 years, Medicare still wont cover it.

Medicares non-coverage policy is in conflict with Congresss intent, which was to promote medical innovation. Back in 2003, they passed the Medicare Modernization Act, which made it clear: new technologies not covered under Part B should be covered under Part D, which covers medicines. Medicare hasnt used that authority to cover the Omnipod either. But it should.

Because Omnipod isnt covered under Medicare, the Federal government is forcing seniors like me to abandon the treatment we need.

Now Im fortunate: After paying out of pocket since I turned 65, I recently found out that my Express Scripts Medicare Advantage plan has decided to stop mirroring Medicares policy. Thanks to that decision, I will get the coverage I need. But millions of people arent as fortunate they rely on other Medicare and Medicare Advantage plans where Omnipod still isnt covered.

Every major diabetes patient and medical advocacy group agrees: There should be no reason why the Omnipod remains the only FDA-approved insulin pump not covered by Medicare. Theyve urged the Centers for Medicare and Medicaid Services to cover the Omnipod. And Im urging them now, too.

Medicare should cover Omnipod, because it is a critical part of my medical plan. I shouldnt be forced to lose it just because Ive turned 65and neither should any other senior.

A small business owner, Sally Hillerich Galla is a 40-year veteran of the health insurance industry who lives in Eastern Jefferson County with her husband, Patrick.

Read or Share this story: http://www.courier-journal.com/story/opinion/contributors/2017/06/15/expand-coverage-diabetes-treatment-sally-hillerich-galla/399244001/

Originally posted here:
Expand coverage for diabetes treatment | Sally Hillerich Galla - The Courier-Journal

Posted in Diabetes | Comments Off on Expand coverage for diabetes treatment | Sally Hillerich Galla – The Courier-Journal

Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents – Reason (blog)

Posted: June 15, 2017 at 9:43 pm

Glassholic/FoterIn considering the rights of Native American foster children, should the emphasis be placed on their status as Native Americans or as children?

The Arizona Supreme Court chose the latter, clearing a non-native couple to adopt their foster daughter over objections of a local Indian tribe.

The court's ruling is a challenge to the controversial 1978 Indian Child Welfare Act (ICWA). Proponents say the act is essential to keep Native American communities together. Critics contend it establishes a racially discriminatory system that negatively affects the safety and welfare of Indian children.

At the time of ICWA's passage, removal of Native American children from their homes was "truly an epidemic that threatened native American children and their families," David E. Simmons, Government Affairs Director for the National Indian Child Welfare Association, tells Reason.

ICWA sought to stem this so-called epidemic by conferring upon sovereign tribal nations the right to be involved in the adoption process of their citizens. Tribes were free to employ "community-based services and community-based knowledge" in deciding on the placement of children.

ICWA, however, has little do with the legal or cultural attachment of a child to a tribal community, and everything to do with a biological attachment to a racial group, Timothy Sandefur, Vice President for Litigation at the Goldwater Institute, says.

The Goldwater Institute has intervened in a number of ICWA cases including this most recent one in Arizona.

"If you have the right blood cells in your veins, then ICWA applies a separate and substandard set of rules that makes it harder to protect you from abuse and neglect, and harder to find you an adoptive home," Sanderfur says.

In 2014 an infant identified as A.D. in court documents was born to a member of the Gila River Indian Community. Both A.D. and her mother tested positive for amphetamines and opiates and the Arizona Department of Child Services ordered the child placed her current non-native foster parents.

Sarah and Jeremy H., according to the court documents, moved to adopt A.D in Arizona state court in June 2015. But despite repeated failures to find a suitable tribal family for A.D., the Gila River Indian Community blocked the adoption claiming tribal court jurisdiction through ICWA.

The Arizona Supreme Court unanimously rejected the Gila River Indian Community's argument, but broader concerns about the authority of ICWA remain. The act's departure from standard adoption law has exposed Native American children to parents who have systemically physically and sexually abused them, Sandefur says.

Laws that govern foster care for children of all other races, by contrast, require "reasonable efforts" be made to reunite children and parents, but draw the line at trying to return kids to homes where they have experienced "systemic abuse."

One example was the case of Shayla H. Under the ICWA requirement she was returned to a sexually abusive fathera member of the Rosebud Sioux Tribeonly to be removed a month later after further incidences of sexual abuse.

In Minnesota, three siblings were removed and returned to their alcoholic parents so many times child services workers stopped counting at 500.

At the behest of the North Dakota Spirit Lake tribe, Laurynn Whiteshield and her twin sister, were taken from a non-native foster family and placed with her Native American grandfather and a step-grandmother charged eight total with child abuse.

A little more than a month later the step-grandmother was charged with murdering Laurynn Whiteshield.

The most recent Arizona case, Sandefur says, was a narrow victory decided on more technical and procedural grounds. The Goldwater Institute has brought a class action suit in federal court on behalf of off-reservation Indian children subject to ICWA to broaden its impact.

The case is currently before the Ninth Circuit Court of Appeal.

The goal, Sandefur says, is not to strike down the entire law or undermine the authority of Indian tribes.

"It [ICWA] needs to be amended," he says, "with the principle in mind that all Indian children are citizens of the United States entitled to equal protection of the laws, and that means no separate rules based on biology."

More:
Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents - Reason (blog)

Posted in Arizona Stem Cells | Comments Off on Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents – Reason (blog)

Page 1,536«..1020..1,5351,5361,5371,538..1,5501,560..»